Increased invasive behaviour in cutaneous squamous cell carcinoma with loss of basement-membrane type VII collagen

Journal of Cell Science

Volumn 122, Issue 11, 2009, Pages 1788-1799

  Martins, Vera L ^a   Vyas, Jashmin J ^a   Chen, Mei ^c   Purdie, Karin ^a,b   Mein, Charles A ^a   South, Andrew P ^d   Storey, Alan ^e   McGrath, John A ^f   O'Toole, Edel A ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF DUNDEE   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Collagen; Invasion; Skin; Squamous cell carcinoma

Indexed keywords

CHEMOKINE RECEPTOR CXCR3; COLLAGEN TYPE 7; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE A; INVOLUCRIN; MESSENGER RNA; SMALL INTERFERING RNA;

ARTICLE; BASEMENT MEMBRANE; CANCER INVASION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EPIDERMOLYSIS BULLOSA DYSTROPHICA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

BASEMENT MEMBRANE; BIOLOGICAL MARKERS; CADHERINS; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL MOVEMENT; COLLAGEN TYPE VII; HUMANS; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NEOPLASM INVASIVENESS; PROTEIN PRECURSORS; RNA, SMALL INTERFERING; SKIN NEOPLASMS; TISSUE CULTURE TECHNIQUES;

EID: 69449084464     PISSN: 00219533     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.042895     Document Type: Article

References (65)

1. Ao, M., Franco, O. E., Park, D., Raman, D., Williams, K. and Hayward, S. W. (2007). Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Cancer Res. 67, 4244-4253.
2. Arbiser, J. L., Fine, J. D., Murrell, D., Paller, A., Connors, S., Keough, K., Marsh, E. and Folkman, J. (1998). Basic fibroblast growth factor: a missing link between collagen VII, increased collagenase, and squamous cell carcinoma in recessive dystrophic epidermolysis bullosa. Mol. Med. 4, 191-195.
3. Arbiser, J. L., Fan, C. Y., Su, X., Van Emburgh, B. O., Cerimele, F., Miller, M. S., Harvell, J. and Marinkovich, M. P. (2004). Involvement of p53 and p16 tumor suppressor genes in recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma. J. Invest. Dermatol. 123, 788-790.
4. Bach, T. L., Chen, Q. M., Kerr, W. T., Wang, Y., Lian, L., Choi, J. K., Wu, D., Kazanietz, M. G., Koretzky, G. A., Zigmond, S. et al. (2007). Phospholipase cbeta is critical for T cell chemotaxis. J. Immunol. 179, 2223-2227.
5. Bartolome, R. A., Galvez, B. G., Longo, N., Baleux, F., Van Muijen, G. N., Sanchez-Mateos, P., Arroyo, A. G. and Teixido, J. (2004). Stromal cell-derived factor-1alpha promotes melanoma cell invasion across basement membranes involving stimulation of membrane-type 1 matrix metalloproteinase and Rho GTPase activities. Cancer Res. 64, 2534-2543.
6. Bierie, B. and Moses, H. L. (2006). TGFbeta and cancer. Cytokine Growth Factor Rev. 17, 29-40.
7. Bloor, B. K., Tidman, N., Leigh, I. M., Odell, E., Dogan, B., Wollina, U., Ghali, L. and Waseem, A. (2003). Expression of keratin K2e in cutaneous and oral lesions: association with keratinocyte activation, proliferation, and keratinization. Am. J. Pathol. 162, 963-975.
8. Bodemer, C., Tchen, S. I., Ghomrasseni, S., Seguier, S., Gaultier, F., Fraitag, S., de Prost, Y. and Godeau, G. (2003). Skin expression of metalloproteinases and tissue inhibitor of metalloproteinases in sibling patients with recessive dystrophic epidermolysis and intrafamilial phenotypic variation. J. Invest. Dermatol. 121, 273-279.
9. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P. and Cheresh, D. A. (1996). Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85, 683-693.
10. Campbell, C., Quinn, A. G. and Rees, J. L. (1993). Codon 12 Harvey-ras mutations are rare events in non-melanoma human skin cancer. Br. J. Dermatol. 128, 111-114.
11. Cha, D., O'Brien, P., O'Toole, E. A., Woodley, D. T. and Hudson, L. G. (1996). Enhanced modulation of keratinocyte motility by transforming growth factor-alpha (TGFalpha) relative to epidermal growth factor (EGF). J. Invest. Dermatol. 106, 590-597.
12. Chan, T. A., Glockner, S., Yi, J. M., Chen, W., Van Neste, L., Cope, L., Herman, J. G., Velculescu, V., Schuebel, K. E., Ahuja, N. et al. (2008). Convergence of mutation and epigenetic alterations identifies common genes in cancer that predict for poor prognosis. PLoS Med. 5, e114.
13. Chen, M., Marinkovich, M. P., Veis, A., Cai, X., Rao, C. N., O'Toole, E. A. and Woodley, D. T. (1997). Interactions of the amino-terminal noncollagenous (NC1) domain of type VII collagen with extracellular matrix components. A potential role in epidermal-dermal adherence in human skin. J. Biol. Chem. 272, 14516-14522.
14. Chen, M., Costa, F. K., Lindvay, C. R., Han, Y. P. and Woodley, D. T. (2002a). The recombinant expression of full-length type VII collagen and characterization of molecular mechanisms underlying dystrophic epidermolysis bullosa. J. Biol. Chem. 277, 2118-2124.
15. Chen, M., Kasahara, N., Keene, D. R., Chan, L., Hoeffler, W. K., Finlay, D., Barcova, M., Cannon, P. M., Mazurek, C. and Woodley, D. T. (2002b). Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa. Nat. Genet. 32, 670-675.
16. Christiano, A. M., Anhalt, G., Gibbons, S., Bauer, E. A. and Uitto, J. (1994). Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa. Genomics 21, 160-168.
17. Fine, J. D., Johnson, L. B., Weiner, M., Li, K. P. and Suchindran, C. (2009). Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J. Am. Acad. Dermatol. 60, 203-211.
18. Fritsch, A., Loeckermann, S., Kern, J. S., Braun, A., Bosl, M. R., Bley, T. A., Schumann, H., von Elverfeldt, D., Paul, D., Erlacher, M. et al. (2008). A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy. J. Clin. Invest. 118, 1669-1679.
19. Glick, A. B., Perez-Lorenzo, R. and Mohammed, J. (2008). Context-dependent regulation of cutaneous immunological responses by TGFbeta1 and its role in skin carcinogenesis. Carcinogenesis 29, 9-14.
20. Goldberg, G. I., Eisen, A. Z. and Bauer, E. A. (1988). Tissue stress and tumor promotion. Possible relevance to epidermolysis bullosa. Arch. Dermatol. 124, 737-741.
21. Goldberg-Bittman, L., Neumark, E., Sagi-Assif, O., Azenshtein, E., Meshel, T., Witz, I. P. and Ben-Baruch, A. (2004). The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines. Immunol. Lett. 92, 171-178.
22. Gonzales, M., Weksler, B., Tsuruta, D., Goldman, R. D., Yoon, K. J., Hopkinson, S. B., Flitney, F. W. and Jones, J. C. (2001). Structure and function of a vimentin-associated matrix adhesion in endothelial cells. Mol. Biol. Cell 12, 85-100.
23. Grau, A. M., Datta, P. K., Zi, J., Halder, S. K. and Beauchamp, R. D. (2006). Role of Smad proteins in the regulation of NF-kappaB by TGFbeta in colon cancer cells. Cell. Signal. 18, 1041-1050.
24. Han, G., Lu, S. L., Li, A. G., He, W., Corless, C. L., Kulesz-Martin, M. and Wang, X. J. (2005). Distinct mechanisms of TGFbeta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis. J. Clin. Invest. 115, 1714-1723.
25. Harris, A., Harris, H. and Hollingsworth, M. A. (2007). Complete suppression of tumor formation by high levels of basement membrane collagen. Mol. Cancer Res. 5, 1241-1245.
26. Kawada, K., Sonoshita, M., Sakashita, H., Takabayashi, A., Yamaoka, Y., Manabe, T., Inaba, K., Minato, N., Oshima, M. and Taketo, M. M. (2004). Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res. 64, 4010-4017.
27. Kawada, K., Hosogi, H., Sonoshita, M., Sakashita, H., Manabe, T., Shimahara, Y., Sakai, Y., Takabayashi, A., Oshima, M. and Taketo, M. M. (2007). Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene 26, 4679-4688.
28. Kivisaari, A. K., Kallajoki, M., Mirtti, T., McGrath, J. A., Bauer, J. W., Weber, F., Konigova, R., Sawamura, D., Sato-Matsumura, K. C., Shimizu, H. et al. (2008). Transformation-specific matrix metalloproteinases (MMP)-7 and MMP-13 are expressed by tumour cells in epidermolysis bullosa-associated squamous cell carcinomas. Br. J. Dermatol. 158, 778-785.
29. Le Beyec, J., Xu, R., Lee, S. Y., Nelson, C. M., Rizki, A., Alcaraz, J. and Bissell, M. J. (2007). Cell shape regulates global histone acetylation in human mammary epithelial cells. Exp. Cell Res. 313, 3066-3075.
30. Leivonen, S. K. and Kahari, V. M. (2007). Transforming growth factor-beta signaling in cancer invasion and metastasis. Int. J. Cancer 121, 2119-2124.
31. Levy, L. and Hill, C. S. (2005). Smad4 dependency defines two classes of transforming growth factor {beta} (TGF{beta}) target genes and distinguishes TGF{beta}-induced epithelial-mesenchymal transition from its antiproliferative and migratory responses. Mol. Cell. Biol. 25, 8108-8125.
32. Li, A. G., Lu, S. L., Zhang, M. X., Deng, C. and Wang, X. J. (2004a). Smad3 knockout mice exhibit a resistance to skin chemical carcinogenesis. Cancer Res. 64, 7836-7845.
33. Li, A. G., Wang, D., Feng, X. H. and Wang, X. J. (2004b). Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. EMBO J. 23, 1770-1781.
34. Li, A. G., Lu, S. L., Han, G., Hoot, K. E. and Wang, X. J. (2006). Role of TGFbeta in skin inflammation and carcinogenesis. Mol. Carcinog. 45, 389-396.
35. Lu, S. L., Reh, D., Li, A. G., Woods, J., Corless, C. L., Kulesz-Martin, M. and Wang, X. J. (2004a). Overexpression of transforming growth factor beta1 in head and neck epithelia results in inflammation, angiogenesis, and epithelial hyperproliferation. Cancer Res. 64, 4405-4410.
36. Lu, T., Burdelya, L. G., Swiatkowski, S. M., Boiko, A. D., Howe, P. H., Stark, G. R. and Gudkov, A. V. (2004b). Secreted transforming growth factor beta2 activates NF-kappaB, blocks apoptosis, and is essential for the survival of some tumor cells. Proc. Natl. Acad. Sci. USA 101, 7112-7117.
37. Mallipeddi, R., Wessagowit, V., South, A. P., Robson, A. M., Orchard, G. E., Eady, R. A. and McGrath, J. A. (2004). Reduced expression of insulin-like growth factor-binding protein-3 (IGFBP-3) in Squamous cell carcinoma complicating recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 122, 1302-1309.
38. McGrath, J. A., Ishida-Yamamoto, A., O'Grady, A., Leigh, I. M. and Eady, R. A. (1993). Structural variations in anchoring fibrils in dystrophic epidermolysis bullosa: correlation with type VII collagen expression. J. Invest. Dermatol. 100, 366-372.
39. Morrison, A. I., Keeble, S. and Watt, F. M. (1988). The peanut lectin-binding glycoproteins of human epidermal keratinocytes. Exp. Cell Res. 177, 247-256.
40. Nystrom, M. L., Thomas, G. J., Stone, M., Mackenzie, I. C., Hart, I. R. and Marshall, J. F. (2005). Development of a quantitative method to analyse tumour cell invasion in organotypic culture. J. Pathol. 205, 468-475.
41. Ojeh, N. O., Frame, J. D. and Navsaria, H. A. (2001). In vitro characterization of an artificial dermal scaffold. Tissue Eng. 7, 457-472.
42. Onoue, T., Uchida, D., Begum, N. M., Tomizuka, Y., Yoshida, H. and Sato, M. (2006). Epithelial-mesenchymal transition induced by the stromal cell-derived factor-1/CXCR4 system in oral squamous cell carcinoma cells. Int. J. Oncol. 29, 1133-1138.
43. Ortiz-Urda, S., Garcia, J., Green, C. L., Chen, L., Lin, Q., Veitch, D. P., Sakai, L. Y., Lee, H., Marinkovich, M. P. and Khavari, P. A. (2005). Type VII collagen is required for Ras-driven human epidermal tumorigenesis. Science 307, 1773-1776.
44. Popp, S., Waltering, S., Holtgreve-Grez, H., Jauch, A., Proby, C., Leigh, I. M. and Boukamp, P. (2000). Genetic characterization of a human skin carcinoma progression model: from primary tumor to metastasis. J. Invest. Dermatol. 115, 1095-1103.
45. Pourreyron, C., Cox, G., Mao, X., Volz, A., Baksh, N., Wong, T., Fassihi, H., Arita, K., O'Toole, E. A., Ocampo-Candiani, J. et al. (2007). Patients with recessive dystrophic epidermolysis bullosa develop squamous-cell carcinoma regardless of type VII collagen expression. J. Invest. Dermatol. 127, 2438-2444.
46. Proby, C. M., Purdie, K. J., Sexton, C. J., Purkis, P., Navsaria, H. A., Stables, J. N. and Leigh, I. M. (2000). Spontaneous keratinocyte cell lines representing early and advanced stages of malignant transformation of the epidermis. Exp. Dermatol. 9, 104-117.
47. Ryynanen, J., Sollberg, S., Olsen, D. R. and Uitto, J. (1991). Transforming growth factor-beta up-regulates type VII collagen gene expression in normal and transformed epidermal keratinocytes in culture. Biochem. Biophys. Res. Commun. 180, 673-680.
48. Said, J. W., Sassoon, A. F., Shintaku, I. P. and Banks-Schlegel, S. (1984). Involucrin in squamous and basal cell carcinomas of the skin: an immunohistochemical study. J. Invest. Dermatol. 82, 449-452.
49. Shimoyama, Y., Hirohashi, S., Hirano, S., Noguchi, M., Shimosato, Y., Takeichi, M. and Abe, O. (1989). Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res. 49, 2128-2133.
50. Silletti, S., Kessler, T., Goldberg, J., Boger, D. L. and Cheresh, D. A. (2001). Disruption of matrix metalloproteinase 2 binding to integrin alpha vbeta 3 by an organic molecule inhibits angiogenesis and tumor growth in vivo. Proc. Natl. Acad. Sci. USA 98, 119-124.
51. Smoller, B. A., McNutt, N. S., Carter, D. M., Gottlieb, A. B., Hsu, A. and Krueger, J. (1990a). Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis. Arch. Dermatol. 126, 78-83.
52. Smoller, B. R., Krueger, J., McNutt, N. S. and Hsu, A. (1990b). "Activated" keratinocyte phenotype is unifying feature in conditions which predispose to squamous cell carcinoma of the skin. Mod. Pathol. 3, 171-175.
53. Titeux, M., Pendaries, V., Tonasso, L., Decha, A., Bodemer, C. and Hovnanian, A. (2008). A frequent functional SNP in the MMP1 promoter is associated with higher disease severity in recessive dystrophic epidermolysis bullosa. Hum. Mutat. 29, 267-276.
54. Valcourt, U., Kowanetz, M., Niimi, H., Heldin, C. H. and Moustakas, A. (2005). TGFbeta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. Mol. Biol. Cell 16, 1987-2002.
55. van der Schroeff, J. G., Evers, L. M., Boot, A. J. and Bos, J. L. (1990). Ras oncogene mutations in basal cell carcinomas and squamous cell carcinomas of human skin. J. Invest. Dermatol. 94, 423-425.
56. Varki, R., Sadowski, S., Uitto, J. and Pfendner, E. (2007). Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J. Med. Genet. 44, 181-192.
57. Veitch, D. P., Nokelainen, P., McGowan, K. A., Nguyen, T. T., Nguyen, N. E., Stephenson, R., Pappano, W. N., Keene, D. R., Spong, S. M., Greenspan, D. S. et al. (2003). Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J. Biol. Chem. 278, 15661-15668.
58. Vindevoghel, L., Lechleider, R. J., Kon, A., de Caestecker, M. P., Uitto, J., Roberts, A. B. and Mauviel, A. (1998). SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc. Natl. Acad. Sci. USA 95, 14769-14774.
59. Walser, T. C., Rifat, S., Ma, X., Kundu, N., Ward, C., Goloubeva, O., Johnson, M. G., Medina, J. C., Collins, T. L. and Fulton, A. M. (2006). Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer. Cancer Res. 66, 7701-7707.
60. Waterman, E. A., Sakai, N., Nguyen, N. T., Horst, B. A., Veitch, D. P., Dey, C. N., Ortiz-Urda, S., Khavari, P. A. and Marinkovich, M. P. (2007). A laminin-collagen complex drives human epidermal carcinogenesis through phosphoinositol-3-kinase activation. Cancer Res. 67, 4264-4270.
61. Wong, T., Gammon, L., Liu, L., Mellerio, J. E., Dopping-Hepenstal, P. J., Pacy, J., Elia, G., Jeffery, R., Leigh, I. M., Navsaria, H. et al. (2008). Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa. J. Invest. Dermatol. 128, 2179-2189.
62. Wood, L. D., Parsons, D. W., Jones, S., Lin, J., Sjoblom, T., Leary, R. J., Shen, D., Boca, S. M., Barber, T., Ptak, J. et al. (2007). The genomic landscapes of human breast and colorectal cancers. Science 318, 1108-1113.
63. Woodley, D. T., Keene, D. R., Atha, T., Huang, Y., Lipman, K., Li, W. and Chen, M. (2004). Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa. Nat. Med. 10, 693-695.
64. Yokoyama, K., Kamata, N., Fujimoto, R., Tsutsumi, S., Tomonari, M., Taki, M., Hosokawa, H. and Nagayama, M. (2003). Increased invasion and matrix metalloproteinase-2 expression by Snail-induced mesenchymal transition in squamous cell carcinomas. Int. J. Oncol. 22, 891-898.
65. Yoon, Y., Liang, Z., Zhang, X., Choe, M., Zhu, A., Cho, H. T., Shin, D. M., Goodman, M. M., Chen, Z. G. and Shim, H. (2007). CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models. Cancer Res. 67, 7518-7524.